These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 28437390)
21. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection. Lin MV; Sise ME; Pavlakis M; Amundsen BM; Chute D; Rutherford AE; Chung RT; Curry MP; Hanifi JM; Gabardi S; Chandraker A; Heher EC; Elias N; Riella LV PLoS One; 2016; 11(7):e0158431. PubMed ID: 27415632 [TBL] [Abstract][Full Text] [Related]
22. Effectiveness of Sofosbuvir and Ribavirin for Eradicating Hepatitis C Virus in Renal Transplant Recipients in Pakistan: Where Resources Are Scarce. Hanif FM; Laeeq SM; Mandhwani RK; Luck NH; Aziz T; Mehdi SH Exp Clin Transplant; 2017 Feb; 15(Suppl 1):63-67. PubMed ID: 28260436 [TBL] [Abstract][Full Text] [Related]
23. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant. Kamar N; Ribes D; Izopet J; Rostaing L Transplantation; 2006 Oct; 82(7):853-6. PubMed ID: 17038897 [TBL] [Abstract][Full Text] [Related]
24. Treatment of hepatitis C in renal transplantation candidates: a single-center experience. Werner T; Aqel B; Balan V; Byrne T; Carey E; Douglas D; Heilman RL; Rakela J; Mekeel K; Reddy K; Vargas HE Transplantation; 2010 Aug; 90(4):407-11. PubMed ID: 20571469 [TBL] [Abstract][Full Text] [Related]
26. Management of hepatitis B and C in renal failure and renal transplant recipients. Amarapurkar D; Das HS Trop Gastroenterol; 2002; 23(2):49-53. PubMed ID: 12632966 [No Abstract] [Full Text] [Related]
27. Hepatitis C virus infection in end stage renal disease and after kidney transplant. Rodriguez-Castro KI; Morisco F; Rigotti P; Rugge M; Burra P J Gastrointestin Liver Dis; 2014 Sep; 23(3):340-2. PubMed ID: 25267966 [No Abstract] [Full Text] [Related]
28. Hepatitis C virus and nonliver solid organ transplantation. Carbone M; Mutimer D; Neuberger J Transplantation; 2013 Mar; 95(6):779-86. PubMed ID: 23172130 [TBL] [Abstract][Full Text] [Related]
29. Management of hepatitis C infection among patients with renal failure. Latt NL; Araz F; Alachkar N; Durand CM; Gurakar A Minerva Gastroenterol Dietol; 2015 Mar; 61(1):39-49. PubMed ID: 25390288 [TBL] [Abstract][Full Text] [Related]
30. Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection. Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Selçuk H; Haberal M Exp Clin Transplant; 2015 Apr; 13 Suppl 1():159-64. PubMed ID: 25894147 [TBL] [Abstract][Full Text] [Related]
31. Novel Hepatitis C Treatment and the Impact on Kidney Transplantation. Sawinski D; Bloom RD Transplantation; 2015 Dec; 99(12):2458-66. PubMed ID: 26214816 [TBL] [Abstract][Full Text] [Related]
32. Successful Posttransplant Treatment of Hepatitis C With Ledipasvir-Sofosbuvir in HIV+ Kidney Transplant Recipients. Sawinski D; Lee DH; Doyle AM; Blumberg EA Transplantation; 2017 May; 101(5):974-979. PubMed ID: 27467534 [TBL] [Abstract][Full Text] [Related]
33. Outcomes of kidney transplantation recipients with hepatitis in the antiviral therapy era: a single-center experience. Lu K; Wang HP; Chen YS Transplant Proc; 2014; 46(2):460-3. PubMed ID: 24655988 [TBL] [Abstract][Full Text] [Related]
34. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates. Terrault NA; McCaughan GW; Curry MP; Gane E; Fagiuoli S; Fung JYY; Agarwal K; Lilly L; Strasser SI; Brown KA; Gadano A; Kwo PY; Burra P; Samuel D; Charlton M; Pessoa MG; Berenguer M Transplantation; 2017 May; 101(5):945-955. PubMed ID: 28437387 [No Abstract] [Full Text] [Related]
35. Transplantation of Hepatitis C-Infected Kidneys into Uninfected Recipients: A Review of the Literature. Leesley H; Osband AJ R I Med J (2013); 2021 Feb; 104(1):34-36. PubMed ID: 33517597 [No Abstract] [Full Text] [Related]
36. Clinical trials: Treatment of HCV-infected patients with advanced kidney disease. Ladino M; Roth D Nat Rev Nephrol; 2018 Jan; 14(1):6-8. PubMed ID: 29176656 [No Abstract] [Full Text] [Related]
37. When should a hepatitis C-positive ESRD patient receive a renal transplant? Kulkarni S; Taddei TH Semin Dial; 2011; 24(4):438-9. PubMed ID: 21801216 [No Abstract] [Full Text] [Related]
38. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients. Terrault NA; Berenguer M; Strasser SI; Gadano A; Lilly L; Samuel D; Kwo PY; Agarwal K; Curry MP; Fagiuoli S; Fung JYY; Gane E; Brown KA; Burra P; Charlton M; Pessoa MG; McCaughan GW Transplantation; 2017 May; 101(5):956-967. PubMed ID: 28437388 [No Abstract] [Full Text] [Related]
39. Pharmacotherapy of hepatitis C virus infection: a brief review. Quan DJ Nephrol Nurs J; 2009; 36(3):333-7. PubMed ID: 19588704 [TBL] [Abstract][Full Text] [Related]
40. Causes of treatment failure for hepatitis C in the era of direct-acting antiviral therapy. Cabezas J; Llerena S; Puente Á; Fábrega E; Crespo J Rev Esp Enferm Dig; 2016 Jul; 108(7):421-30. PubMed ID: 26666379 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]